ADVERTISEMENT
ADVERTISEMENT
Trump meets Novartis CEO, says drugmaker building 11 U.S. plants
The statement did not add any details on the number of facilities planned in the U.S.
-
Reuters - Fri, 20, Feb 2026
- 03:30 EST
- 31
Chief Executive Officer Novartis Vas Narasimhan attends the 55th annual World Economic Forum (WEF) meeting in Davos, Switzerland, Jan. 22, 2025. / REUTERS/Yves Herman
U.S. President Donald Trump said he met Vas Narasimhan, the chief executive officer of Swiss drugmaker Novartis, at the White House on Feb. 18.
Trump, addressing workers at a steel plant in Rome, Georgia on Feb. 19, said Narasimhan told him during the meeting that his company was building 11 U.S. plants as a result of the president's tariff policies.
ALSO READ: Novartis CEO defends $12 billion deal for Avidity as 'appropriate risk to take'
"We appreciate the opportunity to update the U.S. government on our progress, including recent groundbreakings for manufacturing and research facilities in North Carolina and California and plans to expand our radioligand therapy manufacturing network with a new site in Florida," a spokesperson for Novartis told Reuters in an emailed statement.
The statement did not add any details on the number of facilities planned in the U.S.
Last year, the Swiss drugmaker said it planned to spend $23 billion to build and expand 10 facilities in the U.S. after the Trump administration threatened to impose drug import duties.
Discover more at New India Abroad.
Related
ADVERTISEMENT
ADVERTISEMENT
E Paper
Video
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login